Organigram Global (OGI) Change in Accured Expenses (2018 - 2026)
Organigram Global (OGI) posted quarterly Change in Accured Expenses of -$13.6 million for Q1 2026, down 469.07% year-over-year from $3.7 million in Q1 2025, and up 17.26% quarter-over-quarter from -$16.4 million in Q4 2025.
Organigram Global (OGI) Change in Accured Expenses (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Change in Accured Expenses for 7 consecutive years, with -$13.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 469.07% year-over-year to -$13.6 million; the TTM figure through Mar 2026 stood at -$40.7 million (down 1585.25% YoY), while the FY2021 annual figure was $170000.0, changed N/A from the prior year.
- Change in Accured Expenses improved to -$13.6 million in Q1 2026 per OGI's latest filing, from -$16.4 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at -$2.4 million in Q1 2025 and bottomed at -$16.4 million in Q4 2025.
- Historically, Change in Accured Expenses has averaged -$10.2 million across 3 years, with a median of -$10.9 million in 2026.
- Annual changes were most pronounced in 2025 — Change in Accured Expenses plunged 98.59% — and 2026, when it plunged 469.07%.
- Organigram Global's Change in Accured Expenses stood at -$8.3 million in 2024, then slumped by 98.59% to -$16.4 million in 2025, then increased by 17.26% to -$13.6 million in 2026.
- Business Quant data shows OGI's Change in Accured Expenses at -$13.6 million in Q1 2026, -$16.4 million in Q4 2025, and -$2.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Organigram Global | 151.29 Mn | 151.17 Mn | 28.97 Mn | -13.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.60 Mn |
| Mar 31, 2026 | -13.60 Mn |
| Dec 31, 2025 | -16.43 Mn |
| Dec 31, 2025 | -16.43 Mn |
| Mar 31, 2025 | -2.39 Mn |
| Mar 31, 2025 | -2.39 Mn |
| Dec 31, 2024 | -8.27 Mn |
| Dec 31, 2024 | -8.27 Mn |
| May 31, 2021 | 4.38 Mn |
| May 31, 2021 | 4.38 Mn |
| Feb 28, 2021 | 3.87 Mn |
| Feb 28, 2021 | 3.87 Mn |
| Nov 30, 2020 | -322,000.00 |
| Nov 30, 2020 | -322,000.00 |
| May 31, 2020 | 7.79 Mn |
| May 31, 2020 | 7.79 Mn |
| Feb 29, 2020 | 15,458.00 |
| Feb 29, 2020 | 15,458.00 |
| May 31, 2019 | 6.27 Mn |
| May 31, 2019 | 6.27 Mn |